P
Peter A. E. Sillevis Smitt
Researcher at Erasmus University Rotterdam
Publications - 168
Citations - 10393
Peter A. E. Sillevis Smitt is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Glioma & Cancer. The author has an hindex of 53, co-authored 162 publications receiving 8705 citations. Previous affiliations of Peter A. E. Sillevis Smitt include Memorial Sloan Kettering Cancer Center & University of Pennsylvania.
Papers
More filters
Journal ArticleDOI
Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology
Lonneke A.M. Gravendeel,Mathilde C.M. Kouwenhoven,Olivier Gevaert,Johan J. de Rooi,Andrew P. Stubbs,J Elza Duijm,Anneleen Daemen,Fonnet E. Bleeker,Linda B. C. Bralten,Nanne K. Kloosterhof,Bart De Moor,Paul H. C. Eilers,Peter J. van der Spek,Johan M. Kros,Peter A. E. Sillevis Smitt,Martin J. van den Bent,Pim J. French +16 more
TL;DR: The data provide compelling evidence that expression profiling is a more accurate and objective method to classify gliomas than histologic classification, and molecular classification therefore may aid diagnosis and can guide clinical decision making.
Journal ArticleDOI
Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients
Setareh Shams'ili,Joost Grefkens,Bertie de Leeuw,Martin J. van den Bent,Herbert Hooijkaas,Bronno van der Holt,Charles J. Vecht,Peter A. E. Sillevis Smitt +7 more
TL;DR: The relative frequency of the antineuronal antibodies associated with PCD is examined, the neurological symptoms and signs, associated tumours, disability and survival between groups of PCD with different antibodies are compared and patient-, tumour- and treatment-related characteristics are attempted.
Journal ArticleDOI
Incidence of early pseudo‐progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide
Walter Taal,Dieta Brandsma,Hein G. de Bruin,Jacoline E C Bromberg,Annemarie T. Swaak-Kragten,Peter A. E. Sillevis Smitt,Corine A. van Es,Martin J. van den Bent +7 more
TL;DR: The occurrence of early pseudo‐progression was retrospectively assessed in a cohort of malignant glioma patients treated with RT/TMZ.
Journal ArticleDOI
Anti-LGI1 encephalitis Clinical syndrome and long-term follow-up
Agnes van Sonderen,Roland D. Thijs,Elias C. Coenders,Lize C. Jiskoot,Esther Sanchez,Marienke A.A.M. de Bruijn,Marleen H. van Coevorden-Hameete,Paul W. Wirtz,Marco W.J. Schreurs,Peter A. E. Sillevis Smitt,Maarten J. Titulaer +10 more
TL;DR: Anti-LGI1 encephalitis is a homogenous clinical syndrome, showing early FBDS and other focal seizures with subtle clinical manifestations, followed by memory disturbances, which will lead to earlier diagnosis, essential for prompt start of treatment.
Journal ArticleDOI
The clinical spectrum of Caspr2 antibody–associated disease
Agnes van Sonderen,Helena Ariño,Mar Petit-Pedrol,Frank Leypoldt,Peter Körtvelyessy,Klaus-Peter Wandinger,Eric Lancaster,Paul W. Wirtz,Marco W.J. Schreurs,Peter A. E. Sillevis Smitt,Francesc Graus,Josep Dalmau,Maarten J. Titulaer +12 more
TL;DR: A large cohort of patients with antibodies against contactin-associated protein-like 2 (Caspr2) and the clinical spectrum of this disorder is reported, finding that the resulting syndrome may vary among patients but it usually includes a set of well-established symptoms.